Plenvu is named as an intervention in 2 current clinical trials in our UK, Germany, Spain, Italy, Netherlands, Belgium, Poland and Denmark registers. 2 are recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is Norgine (1). The most-studied condition is Bowel Cleansing Prior to Clinical Procedures.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Trial to Compare Efficacy and Tolerability of Plenvu® and Picoprep® as Cleansing Agents Before Colonoscopy
NCT05436054 · ClinicalTrials.gov ↗ · Colon Disease
|
Phase 4 | Recruiting | Aalborg University Hospital | Denmark |
|
A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy
NCT07218523 · Bowel Cleansing Prior to Clinical Procedures
|
Phase 3 | Recruiting | Norgine | UK, Germany, Spain, Italy, Netherlands, Belgium, Poland |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Norgine | 1 |
| Aalborg University Hospital | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our UK, Germany, Spain, Italy, Netherlands, Belgium, Poland and Denmark registers name Plenvu (also registered as NER1006) as a drug or biological intervention, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 2 trials are recruiting: 1 with sites in UK, 1 with sites in Germany, 1 with sites in Spain, 1 with sites in Italy, 1 with sites in Netherlands, 1 with sites in Belgium, 1 with sites in Poland and 1 with sites in Denmark. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Norgine (1) and Aalborg University Hospital (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Plenvu works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Plenvu works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Plenvu (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 27 Sep 2026.